SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015070
Filing Date
2019-05-02
Accepted
2019-05-02 09:52:36
Documents
76
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20190331.htm 10-Q 1974677
2 EX-10.1 mcrb-ex101_320.htm EX-10.1 305943
3 EX-31.1 mcrb-ex311_9.htm EX-31.1 10565
4 EX-31.2 mcrb-ex312_6.htm EX-31.2 10521
5 EX-32.1 mcrb-ex321_7.htm EX-32.1 7363
6 EX-32.2 mcrb-ex322_10.htm EX-32.2 7454
  Complete submission text file 0001564590-19-015070.txt   6572492

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mcrb-20190331.xml EX-101.INS 1211387
8 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20190331.xsd EX-101.SCH 49537
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20190331_cal.xml EX-101.CAL 50954
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20190331_def.xml EX-101.DEF 131774
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20190331_lab.xml EX-101.LAB 372145
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20190331_pre.xml EX-101.PRE 288302
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 19790155
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences